The anti-inflammatory peptide stearyl-norleucine-VIP delays disease onset and extends survival in a rat model of inherited amyotrophic lateral sclerosis

Article ID	Journal	Published Year	Pages	File Type
6017503	Experimental Neurology	2015	11 Pages	PDF

Keywords

FGF2 NF-κB IGF-1 IL-10 IL-1β GDNF GLT-1 iNOS VIP PACAP GAPDH SOD1 GFAP IBA1 CD11B IL-6 PBS SNV NFκ-B BDNF amyotrophic lateral sclerosis insulin-like growth factor-1 Interleukin-10 interleukin-6 Interleukin-1 beta ALS tumor necrosis factor-alpha glutamate transporters inducible nitric oxide synthase superoxide dismutase 1 fibroblast growth factor 2 Glial cell line-derived neurotrophic factor Brain-derived neurotrophic factor TNF-α Nuclear factor-kappa B Phosphate-buffered saline ionized calcium-binding adapter molecule 1 Glial fibrillary acidic protein pituitary adenylate cyclase-activating polypeptide vasoactive intestinal peptide glutamate transporter-1 Glyceraldehyde phosphate dehydrogenase

Related Topics

Life Sciences Neuroscience Neurology

The anti-inflammatory peptide stearyl-norleucine-VIP delays disease onset and extends survival in a rat model of inherited amyotrophic lateral sclerosis

Authors

Stéphanie Goursaud, Sabrina Schäfer, Amélie O. Dumont, Maxime Vergouts, Alessandro Gallo, Nathalie Desmet, Ronald Deumens, Emmanuel Hermans,